Merkel cell carcinoma arising in immunosuppressed patients treated with high-dose ultraviolet A1 (320-400 nm) phototherapy: a report of two cases
- 9 September 2010
- journal article
- case report
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 26 (5), 263-265
- https://doi.org/10.1111/j.1600-0781.2010.00529.x
Abstract
Merkel cell carcinoma (MCC) is an aggressive neuroendocrine tumour of the skin. Though immunodeficiency is the most relevant risk factor, ultraviolet (UV) radiation is also involved, but as of yet we do not know the action spectrum, pattern or dose which would produce a dangerous exposure. A retrospective study of two immunosuppressed patients who developed MCC during, or soon after a treatment cycle with high dose UVA1 exposures was conducted, in order to understand wether repeated exposures to suberythemogenic UVA1 radiation may have a cancerogenic activity provoking MCC in immunosuppressed patients.Keywords
This publication has 4 references indexed in Scilit:
- Absorption Spectra of Human Skin In Vivo in the Ultraviolet Wavelength Range Measured by OptoacousticsPhotochemistry and Photobiology, 2009
- DNA lesions induced by UV A1 and B radiation in human cells: Comparative analyses in the overall genome and in thep53tumor suppressor geneProceedings of the National Academy of Sciences, 2005
- UV‐B‐type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomasInternational Journal of Cancer, 2002
- Merkel-Cell Carcinomas in Patients Treated with Methoxsalen and Ultraviolet A RadiationNew England Journal of Medicine, 1998